Nitroglycerin Versus Terbutaline for Intrapartum Fetal Resuscitation

Not Applicable

Completed

• Conditions: Fetal Distress
• Interventions: Drug: Terbutaline

• Registration Number: NCT00185887
• Lead Sponsor: Stanford University

Brief Summary

To compare nitroglycerin and terbutaline for intrapartum fetal heart rate resuscitation

Detailed Description

Not available

Study Timeline

• Study Start: 2003-10
• Study First Submitted: 2005-09-12
• Study First Submitted QC: 2005-09-12
• Study First Posted: 2005-09-16
• Primary Completion: 2006-07
• Study Completion: 2007-10
• Status Verified: 2011-03
• Last Update Submitted: 2011-03-04
• Last Update Posted: 2011-03-08

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 110

Inclusion Criteria

:

• nonreassuring fetal heart rate tracing

Exclusion Criteria

• maternal cardiac disease, placental abruption, intrauterine growth restriction, prior cesarean section

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Terbutaline	Terbutaline	-
Nitroglycerine	Terbutaline	-

Primary Outcome Measures

Name	Time	Method
resolution of abnormal fetal heart tracing	Administration of study medication to resolution of abnormal fetal heart tracing or operative delivery.

Secondary Outcome Measures

Name	Time	Method
cesarean section rate	Data analysis
operative vaginal delivery rate	Data analysis
neonatal outcomes	time of delivery to time of discharge

Trial Locations

Locations (1)

Stanford University School of Medicine; 🇺🇸 Stanford, California, United States